Created in 1996, the ARUP Institute seeks to expand the quantity, quality, efficiency, and sophistication of laboratory tests. Since its inception, the Research Institute has developed 335 new esoteric laboratory tests that are offered to our clients. Moreover, the research scientists have shared their knowledge, experience, and new developments with the scientific community by publishing more than 1,000 original peer-reviewed research publications in leading journals.
The ARUP Institute’s mission is to be at the forefront of innovative research and development in clinical and experimental
laboratory medicine and to continually contribute to the profession.
The ARUP Institute's focus covers the spectrum of medical laboratory medicine:
Executive Director
|
Project CategoriesGenerally, the ARUP Institute sponsors projects within four broad categories: creating new laboratory tests; improving current clinical laboratory tests; evaluating and critiquing tests, including alpha- and beta-site protocols; and conducting basic and clinical research projects. Research performed on human subjects is conducted under informed consent following the protocols approved by the University of Utah Institutional Review Board (IRB).
|
Hill HR. Group A streptococcal carrier versus acute infection: the continuing dilemma. Clin Infect Dis 2010;50(4):491–2.
Kushnir MM, et al. High sensitivity measurement of estrone and estradiol in serum and plasma using LC-MS/MS. Methods Mol Biol 2010;603:219–28.
Yue B, et al. Quantitation of nicotine, its metabolites, and other related alkaloids in urine, serum, and plasma using LC-MS-MS. Methods Mol Biol 2010;603:389–98.
Vaughn CP, Wilson AR, Samowitz WS. Quantitative evaluation of CpG island methylation in hyperplastic polyps. Mod Pathol 2010;23(1):151–6.
Welch RJ, Litwin CM. Evaluation of two immunoblot assays and a Western blot assay for the detection of antisyphilis immunoglobulin g antibodies. Clin Vaccine Immunol 2010;17(1):183–4.
Guan Y, et al. G-rich oligonucleotides inhibit HIF-1alpha and HIF-2alpha and block tumor growth. Mol Ther 2010;18(1):188–97.